(The) downgraded Chemours Company (The) from a "buy" rating to a "neutral" rating and raised their target price for the company from $23.00 to $27.00 in a report on Monday, December 12th. One analyst has rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the company's stock. The company presently has an average rating of "Hold" and an average price target of $17.22.
Shares of Chemours Company (NYSE:CC) opened at 32.68 on Thursday. The stock has been rated an average of 2.6 by 5 Brokerage Firm. The Stock now has the market capitalization of $5.82 Billion, P/E (price to earnings ttm) of 39.21 and Weekly volatility of 3.16% and monthly volatility of 3.52% respectively. It has gained $0.71 (-2.17%) since hitting a 52-week high price of $32.78 on February 13, 2017.
Many research firms have provided their ratings on The Chemours Company (NYSE:CC) where Goldman provided Buy rating on the stock on 13-Feb-17. If you are viewing this news story on another website, it was illegally copied and republished in violation of worldwide trademark and copyright laws. The correct version of this article can be accessed at https://sportsperspectives.com/2017/02/15/jefferies-group-llc-boosts-chemours-company-the-cc-price-target-to-35-00.html.
Keystone XL Pipeline Proposal Reawakened With Nebraska Application
They say Canada's oil sands, which produce a thick crude oil with a heavy carbon footprint, should stay in the ground. The fate of the Keystone XL oil pipeline once again rests with a Nebraska commission.
To accommodate long-term intention, the firm has diverse dividend or yield record, CC has Dividend Yield of 0.43% and experts calculate Return on Investment of -0.80%. The ex-dividend date of this dividend was Tuesday, November 15th.
The stock now has its Annual Dividend of $0.12 and an annual Dividend Yield of 0.37 Percent. Analysts had expected The Chemours Company (NYSE:CC) to post net income of about $0.34 per share on $1,406.74M in revenue. Mitsubishi UFJ Trust & Banking Corp now owns 25,954 shares of the company's stock valued at $415,000 after buying an additional 182 shares in the last quarter. The 52-week low of the share price is $3.52. Price moves in a company's bonds in credit markets often predict parallel moves in its stock price. Her Majesty the Queen in Right of the Province of Alberta as represented by Alberta Investment Management Corp purchased a new stake in shares of Chemours Company (The) during the third quarter valued at about $1,914,000. Finally, Caxton Associates LP acquired a new position in Chemours Company (The) during the fourth quarter worth about $7,842,000.
07/28/2015 - Susquehanna began new coverage on Chemours giving the company a " rating. The Short Ratio for the stock is 2.07. Goldman Sachs Group, Inc.
Iran conducts second missile test in less than 2 weeks
Trump is slated to meet with Prime Minister Benjamin Netanyahu next week and Iran is expected to be at the top of the agenda. Iran has dismissed the concerns over its missile program, calling the tests exclusively for defensive purposes.
The Chemours Company (NYSE:CC) closed 102.9% above its 200-day moving average which many technicians use as a guide to the long-term trend, so stocks above the line are considered to be in longer-term uptrends, while those below it are considered to be in downtrends.
Full-year profit views are for The Chemours Company to earn $1.22 in current year and grow profits by almost -31.07% over last year's earnings of $1.77. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions.
Venezuelan court upholds sentence against opposition leader
Maduro, who frequently blames Venezuela's ills on the US , had said little about the new administration until today. Maduro on Tuesday demanded the United States apologize for the sanctions and vowed to respond "forcefully".